From research to skills in marine engineering

The Institute of Sound and Vibration Research (ISVR) at the University of Southampton, has developed a productive strategic partnership with Halyard – a manufacturer of marine exhaust systems – which spans research, consultancy and skills development.

Halyard specialises in noise reduction systems for boats and yachts. In 2003, responding to new EU regulations limiting the permissible noise generation on leisure craft, the company initiated a research project to investigate the key elements of noise generation on boats. The project was co-funded by the EU, and led to a fruitful research collaboration with the ISVR at Southampton.

The research identified marine exhaust systems as being the key problem and led to the development of a novel noise measurement device, which allowed Halyard to gain an advantage over its industry rivals.

Halyard approached the ISVR about developing a bespoke course for staff on noise and vibration awareness for its sales and development staff which has been hugely beneficial for Halyard: staff are able to apply technical expertise to an early stage in the design process, and customer satisfaction has improved, with clients evidently impressed by the technical knowledge of Halyard staff. The company was recently rated 9.3 out of 10 for customer satisfaction in this area.

Related case studies

Imperial College London - Breaking new ground in the field of medical technology

The MedTech Superconnector based at Imperial College London's White City Innovation District is supporting researchers to break new ground in the field of medical technology and apply work from the arts and science to early-stage technologies. It has been backed by Research England to expand across the UK

Read more >

Improving survival rates for people with cystic fibrosis

Cystic fibrosis is an inherited condition, caused by a genetic mutation, which affects 75,000 adults and children worldwide. Research at Queen’s University Belfast led to the development of a transformative new drug, Ivacaftor, which has brought outstanding improvements in survival and quality of life for people with the disease. 

Read more >